Brain-derived neurotrophic factor is reduced in Alzheimer's disease

Molecular Brain Research

Volumn 49, Issue 1-2, 1997, Pages 71-81

  Connor, B ^a   Young, D ^a   Yan, Q ^b   Faull, R L M ^a   Synek, B ^a   Dragunow, M ^a  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b AMGEN INC   (United States)

Author keywords

Alzheimer's disease; Brain derived neurotrophic factor; Down's syndrome; Hippocampus; Neurodegeneration

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN PROTEIN; NEUROTROPHIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPORAL CORTEX;

ADULT; AGED; ALZHEIMER DISEASE; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DENTATE GYRUS; DOWN SYNDROME; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POSTMORTEM CHANGES; REFERENCE VALUES; RNA, MESSENGER; TEMPORAL LOBE; TRANSCRIPTION, GENETIC;

EID: 0030658839     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00125-3     Document Type: Article

References (81)

1. Allen S.J., MacGowan S.H., Treanor J.J.S., Feeny R., Wilcock G.K., Dawbarn D. Normal β-NGF content in Alzheimer's disease cerebral cortex and hippocampus. Neurosci. Lett. 131:1991;135-139.
2. Altman L. Programmed cell death: the paths to suicide. Trends Neurosci. 15:1992;278-280.
3. Appel S.H. A unifying hypothesis for the cause of amyotrophic lateral sclerosis, Parkinsonism, and Alzheimer's disease. Ann. Neurol. 10:1981;499-505.
4. Araujo D.M., Chabot J.G., Quirion R. Potential neurotrophic factors in the mammalian central nervous system: functional significance in the developing and aging brain. Int. Rev. Neurobiol. 32:1990;141-173.
5. Araujo D.M., Lapchak P.A., Robitaille Y., Gauthier S., Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of the human brain in Alzheimer's disease. J. Neurochem. 50:1988;1914-1923.
6. Ballarin M., Ernfors P., Lindefors N., Persson H. Hippocampal damage and kainic acid injection induce a rapid increase in BDNF and NGF mRNA in the rat brain. Exp. Neurol. 114:1991;35-43.
7. Berzaghi M.D.P., Cooper J., Castren E., Zafra F., Sofroniew M., Thoenen H., Lindholm D. Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J. Neurosci. 13:1993;3818-3826.
8. Beyreuther K., Bush A.I., Dyrks T., Hilbich C., Konig G., Monning U., Multhaup G., Prior R., Rumble B., Schubert W., Small D.H., Weidemann A., Masters C.L. Mechanisms of amyloid deposition in Alzheimer's disease. Ann. NY Acad. Sci. 640:1991;129-139.
9. Beyreuther K., Pollwein P., Multhaup G., Monning U., Konig G., Dyrks T., Schubert W., Masters C.L. Regulation and expression of the Alzheimer's β/A4 amyloid protein precursor in health, disease and Down's syndrome. Ann. NY Acad. Sci. 695:1993;91-102.
10. Blass J.P., Ko L., Wisniewski H.M. Pathology of Alzheimer's disease. Psychiatry Clin. North America. 14:1991;397-416.
11. Burke M.A., Mobley W.C., Cho J., Wiegand S.J., Lindsay R.M., Mufson E.J., Kordower J.H. Loss of developing cholinergic basal forebrain neurons following excitotoxic lesions of the hippocampus: rescue by neurotrophins. Exp. Neurol. 130:1994;178-195.
12. Comelli M.C., Guidolin D., Seren M.S., Zanoni R., Canella R., Rubini R., Manev H. Time course, localisation and pharmacological modulation of immediate early inducible genes, brain-derived neurotrophic factor and trkB messenger RNAs in the rat brain following photochemical stroke. Neuroscience. 55:1993;473-490.
13. Comelli M.C., Seren M.S., Guidolin D., Manev R.M., Favaron M., Rimland J.M., Canella R., Negro A., Manev H. Photochemical stroke and brain-derived neurotrophic factor (BDNF) mRNA expression. NeuroReport. 3:1992;473-476.
14. Connor B., Young D., Lawlor P., Gai W., Waldvogel H., Faull R.L.M., Dragunow M. Trk receptor alterations in Alzheimer's disease. Mol. Brain Res. 42:1996;1-17.
15. Coyle J.T., Price D.L., DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
16. Crutcher K.A., Scott S.A., Liang S., Everson W.V., Weingartner J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J. Neurosci. 13:1993;2540-2550.
17. Cuello A.C., Sofroniew M.V. The anatomy of the CNS cholinergic neurons. Trends Neurosci. 7:1984;74-78.
18. Cuello C.A. Trophic responses of forebrain cholinergic neurons: a discussion. Prog. Brain Res. 98:1993;265-277.
19. Dragunow M., Beilharz E., Mason B., Lawlor P., Abraham W., Gluckman P. Brain-derived neurotrophic factor expression after long-term potentiation. Neurosci. Lett. 160:1993;232-236.
20. Dragunow M., Beilharz E., Sirimanne E., Lawlor P., Williams C., Bravo R., Gluckman P. Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to young rat brain. Mol. Brain Res. 25:1994;19-33.
21. Dugich-Djordjevic M.M., Peterson C., Isono F., Widmer H.R., Denton T.L., Bennett G.L., Hefti F. Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain. Eur. J. Neurosci. 7:1995;1831-1839.
22. Eide F.F., Vining E.R., Eide B.L., Zang K., Wang X.-Y., Reichardt L.F. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signalling. J. Neurosci. 16:1996;3121-3129.
23. Gall C.M., Gold S.J., Isackson P.J., Seroogy K.B. Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons. Mol. Cell. Neurosci. 3:1992;56-63.
24. Hardy J.A., Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science. 256:1992;184-185.
25. Hefti F. Is Alzheimer's disease caused by lack of nerve growth factor? Ann. Neurol. 13:1983;109-110.
26. Hefti F., Weiner W.J. Nerve growth factor and Alzheimer's disease. Ann. Neurol. 20:1986;275-281.
27. Hsu C.Y., An G., Liu J.S., Xue J.J., He Y.Y., Lin T.H. Expression of immediate early gene and growth factor mRNAs in a focal cerebral ischemia model in the rat. Stroke. 24:1993;I78-I81.
28. Huntley G.W., Benson D.L., Jones E.G., Isackson P.J. Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex. Dev. Brain Res. 70:1992;53-63.
29. Hyman B.T., VanHoesen G.W., Damasio A.R., Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science. 225:1984;1168-1169.
30. Hyman B.T., Van Hoesen G.W., Kromer L.J., Damasio A.R. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann. Neurol. 20:1986;472-481.
31. Jette N., Cole M.S., Fahnestock M. NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients. Mol. Brain Res. 25:1994;242-250.
32. Johnson E.M., Chang J.Y., Koike T., Martin D.P. Why do neurons die when deprived of trophic factors? Neurobiol. Aging. 10:1989;549-552.
33. Kang H., Schuman E.M. Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science. 267:1995;1658-1662.
34. Kang J., Lemaire G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.H., Multhaup G., Beyreither K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
35. Kawamoto Y., Nakamura S., Nakano S., Oka N., Akiguchi I., Kimura J. Immunohistochemical localization of brain-derived neurotrophic factor in adult rat brain. Neuroscience. 74:1996;1209-1226.
36. Knipper M., Berzagh M.D.P., Blochl A., Breer H., Thoenen H., Lindholm D. Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus. Eur. J. Neurosci. 6:1994;668-671.
37. Knusel B., Beck K.D., Winslow J.W., Rosenthal A., Burton L.E., Widmer H.R., Nikolics K., Hefti F. Brain-derived neurotrophic factor administration protects basal brain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J. Neurosci. 12:1992;4391-4402.
38. Kokaia Z., Metsis M., Kokaia M., Bengzon J., Elmer E., Smith M.-L., Timusk T., Siesjo J.K., Persson H., Lindvall O. Brain insults in rats induce increased expression of the BDNF gene through differential use of multiple promotors. Eur. J. Neurosci. 6:1994;587-596.
39. Koliatsos V.E., Clatterbuck R.E., Nauta H.J.W., Knusel B., Burton L.E., Hefti F.F., Mobley W.C., Price D.L. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann. Neurol. 30:1991;831-840.
40. Koliatsos V.E., Price D.L., Clatterbuck R.E., Markowska A.L., Olton D.S., Wilcock B.J. Neurotrophic strategies for treating Alzheimer's disease: lessons from basic neurobiology and animal models. Ann. NY Acad. Sci. 640:1991;292-299.
41. Koliatsos V.E., Price D.L., Gouras G.K., Cayouette M.H., Burton L.E., Winslow J.W. Highly selective effects of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 on intact and injured basal forebrain magnocellular neurons. J. Comp. Neurol. 343:1994;247-262.
42. Kosik K.S. Alzheimer plaques and tangles: advances on both fronts. Trends Neurosci. 14:1991;218-219.
43. Lapchack P.A. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp. Neurol. 124:1993;16-20.
44. Lapchak P.A., Araojo D.M., Hefti F. Systemic interleukin-1β decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience. 53:1993;297-301.
45. Lindefors N., Brodin E., Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus electroconvulsive shock. Neuroscience. 65:1995;661-670.
46. Lindefors N., Ernfors P., Falkenberg T., Persson H. Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and β-nerve growth factor mRNA in rat hippocampus. Exp. Brain Res. 88:1992;78-90.
47. Lindsay R.M. Neurotrophins and receptors. Prog. Brain Res. 103:1994;3-14.
48. Lindsay R.M., Wiegand S.J., Altar C.A., DiStefano P.S. Neurotrophic factors: from molecule to man. Trends Neurosci. 17:1994;182-190.
49. Maness L.M., Kastin A.J., Webber J.T., Banks W.A., Beckman B.S., Zadina J.E. The neurotrophins and their receptors: structure, function, and neuropathology. Neurosci. Biobehav. Rev. 18:1994;143-159.
50. Mann D.M. Is the pattern of nerve cell loss in aging and Alzheimer's disease real, or only apparent, selelctivity? Neurobiol. Aging. 12:1991;340-343.
51. Mattson M.P., Barger S.W., Cheng B., Lieberburg I., Smith-Swintosky V.L., Rydel R.E. β-Amyloid precursor protein metabolites and loss of neuronal calcium homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;409-414.
52. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., Van Belle G., Berg L. The Consortium to establish a registry for Alzheimer's disease (CERAD). Neurology. 41:1991;479-486.
53. Murase K., Nabeshima T., Robitaille Y., Quirion R., Ogawa M., Hayashi K. NGF level is not decreased in the serum, brain-spinal fluid, hippocampus or parietal cortex of individuals with Alzheimer's disease. Biochem. Biophys. Res. Commun. 193:1993;198-203.
54. Murray K.D., Gall C.M., Jones E.G., Isackson P.J. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimers disease. Neuroscience. 60:1994;37-48.
55. Nalbantoglu J. β-Amyloid protein in Alzheimer's disease. Can. J. Neurol. Sci. 18:1991;424-427.
56. Nawa H., Carnahan J., Gail C. BDNF protein measured by a novel enzyme immunoassay in normal brain and after seizure: partial disagreement with mRNA levels. Eur. J. Neurosci. 7:1995;1527-1535.
57. Negro A., Corsa V., Moretto C., Skaper S.D., Callegaro L. Synthesis and purification of biologically active rat brain-derived neurotrophic factor from Escherichia coli. Biochem. Biophys. Res. Commun. 186:1992;1553-1559.
58. Nieto-Sampedro M., Mora F. Active microglia, sick astroglia and Alzheimer type dementias. NeuroReport. 5:1994;375-380.
59. Olson L. NGF and the treatment of Alzheimers disease. Exp. Neurol. 124:1993;5-15.
60. Oppenheim R.W. Cell death during development of the nervous system. Annu. Rev. Neurosci. 14:1991;453-501.
61. Perry R.H., Candy J.M., Perry E.K., Irving D., Blessed G., Fairbairn A.F., Taomlinson B.E. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci. Lett. 33:1982;311-315.
62. Persson G.M.H., Timmusk T., Funakoshi H., Bindoni M., Belluardo N. Increased expression of TrkB and TrkC messenger RNAs in the rat forebrain after focal mechanical injury. Neuroscience. 57:1993;901-912.
63. Phillips H.S., Hains J.M., Armanini M., Laramee G.R., Johnson S.A., Winslow J.W. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron. 7:1991;695-702.
64. Phillips H.S., Hains J.M., Laramee G.R., Rosenthal A., Winslow J.W. Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science. 250:1990;290-293.
65. Rebeck G.W., Hyman B.T. Neuroanatomical connections and specific regional vulnerability in Alzheimer's disease. Neurobiol. Aging. 14:1993;45-47.
66. Regland B., Gottfries C. The role of amyloid β-protein in Alzheimer's disease. Lancet. 340:1992;467-468.
67. Rosenthal A., Goeddel D.V., Nguyen T., Martin E., Burton L.E., Shih A., Laramee G.R., Wurm F., Mason A., Nikolics K., Winslow J.W. Primary structure and biological activity of human brain-derived neurotrophic factor. Endocrinology. 129:1991;1289-1294.
68. Rossor M., Garrett N.J., Johnson A.L., Mountjoy C.Q., Roth M., Iversen L.L. A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain. 105:1982;313-330.
69. Salbaum J.M., Weidemann A., Lemaire H.G., Masters C.L., Beyreuther K. The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO J. 7:1988;2807-2813.
70. Schmidt K.R., Wetmore C., Olson L. Comparative study of brain-derived neurotrophic factor messenger RNA and protein at the cellular level suggests multiple roles in hippocampus, stratum and cortex. Neuroscience. 74:1996;161-183.
71. Takeda A., Onodera H., Sugimoto A., Kogure K., Obinata M., Shibahara S. Coordinated expression of messenger RNAs for nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the rat hippocampus following transcient forebrain ischemia. Neuroscience. 55:1993;23-31.
72. Thoenen H., Bandtlow C., Heumann R. The physiological function of nerve growth factor in the central nervous system: comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109:1987;145-178.
73. Tsukahara T., Yonekawa Y., Tanaka K., Ohara O., Watanabe S., Kimura T., Nishijima T., Taniguchi T. The role of brain-derived neurotrophic factor in transcient forebrain ischemia in the rat brain. Neurosurgery. 34:1994;323-331.
74. Wainer B.H. Neurotrophic factors and Alzheimer's disease. Neurobiol. Aging. 10:1989;540-542.
75. Wetmore C., Cao Y., Pettersson R.F., Olson L. Brain-derived neurotrophic factor: subcellular compartmentalization and interneuronal transfer as visualised with anti-peptide antibodies. Proc. Natl. Acad. Sci. USA. 88:1991;9843-9847.
76. Wetmore C., Ernfors P., Persson H., Olson L. Localisation of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridisation. Exp. Neurol. 109:1990;141-152.
77. Whittemore S.R., Seiger A. The expression, localisation and functional significance of β-nerve growth factor in the central nervous system. Brain Res. Rev. 12:1987;439-464.
78. Wisniewski T., Ghiso J., Frangione B. Alzheimer's disease and soluble Aβ Neurobiol. Aging. 15:1994;143-152.
79. Yan Q., Rosenfeld R.D., Matheson C.R., Hawkins N., Lopez O.T., Bennett L., Welcher A.A. Expression of brain-derived neurotrophic factor (BDNF) protein in the adult rat central nervous system. Neuroscience. 78:1997;431-448.
80. Zafra F., Castren E., Thoene H., Lindholm D. Interplay between glutamate and γ-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nevre growth factor synthesis in hippocampal neurons. Proc. Natl. Acad. Sci. USA. 88:1991;10037-10041.
81. Zafra F., Lindholm D., Castren E., Hartikka J., Thoenen H. Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J. Neurosci. 12:1992;4793-4799.